Discussions

Profacgen delivers cutting-edge high-throughput GPCR screening services that revolutionize GPCR-targeted drug discovery in pharmaceutical development. As G protein-coupled receptors (GPCRs) regulate critical cell signaling pathways and represent over 30% of current therapeutic targets, our optimized screening platform combines fluorescence-based assays, calcium flux analysis, and β-arrestin recruitment detection to identify promising lead compounds. Our customized screening packages feature rapid turnaround times (2-4 weeks), comprehensive data visualization, and mechanism-of-action validation, specifically designed for pharma companies and biotech startups pursuing first-in-class therapeutics.

web: GPCR Screening Service